Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Interleukin-15 receptor alpha subunit isoform 1 is a component of the interleukin-15 (IL-15) receptor complex. It plays a critical role in immune system regulation by binding IL-15 with very high affinity and presenting it to other cells for signaling. The receptor complex consists of IL-2/IL-15Rβ (CD122), common γ chain (CD132), and the unique α-chain: IL‑15Rα. The α-chain confers high-affinity binding to IL‑15 and contains an extracellular Sushi domain essential for ligand interaction. Soluble forms of IL-15Rα are being explored therapeutically for autoimmune diseases or transplant rejection prevention.
Soluble forms can inhibit inflammatory responses by sequestering free cytokine.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Interleukin-15 receptor subunit alpha isoform 1 (IL15RA).